Pet Genetic Testing Companies Are Making Promises They Can’t Keep
By Jessica Hekman,
Undark
| 09. 13. 2018
The promise of a sequenced genome is like a wrapped present, containing exactly what you always wanted but never knew you could get: predictions of all your future health problems and instructions for how to avoid them. Pet owners are the latest to fall prey to the myth of the “magic genome,” hoping that genetic testing will keep their animal companions alive and healthy for longer than ever before. The claims of many genetic testing companies encourage these unrealistic expectations.
The pet genetic testing industry has boomed in recent years as sequencing technology has improved and costs have plummeted. Several companies now tout direct-to-consumer tests that can screen companion animals, mostly dogs, for more than 150 genetic diseases including heart disease, kidney disease, and epilepsy. As a veterinarian and genomics researcher, I encounter dog owners who truly believe that genetic sequencing will save their animals’ lives.
What most pet genetic testing companies fail to make clear, though, is that genetic testing is riddled with uncertainty. Not all pets that test “clear” for a disease are truly safe from that condition...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Nicky Hudson, The Conversation | 08.12.2025